660 related articles for article (PubMed ID: 22835076)
1. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
[TBL] [Abstract][Full Text] [Related]
3. Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1.
Ferretti G; Bacchetti T; Campanati A; Simonetti O; Liberati G; Offidani A
Br J Dermatol; 2012 Jan; 166(1):204-7. PubMed ID: 21790517
[TBL] [Abstract][Full Text] [Related]
4. Methylentetrahydrofolatereductase (rs1801133) polymorphism and psoriasis: contribution to oxidative stress, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report.
Asefi M; Vaisi-Raygani A; Khodarahmi R; Nemati H; Rahimi Z; Vaisi-Raygani H; Tavilani H; Pourmotabbed T
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1192-8. PubMed ID: 24118377
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus.
Bahrehmand F; Vaisi-Raygani A; Ahmadi R; Kiani A; Rahimi Z; Tavilani H; Pourmotabbed T
Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):211-9. PubMed ID: 23893804
[TBL] [Abstract][Full Text] [Related]
6. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
Tanhapour M; Miri A; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Pourmotabbed T; Shakiba E
Clin Rheumatol; 2018 Apr; 37(4):971-977. PubMed ID: 29273831
[TBL] [Abstract][Full Text] [Related]
7. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
[TBL] [Abstract][Full Text] [Related]
8. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
[TBL] [Abstract][Full Text] [Related]
9. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
Hashim Z; Zarina S
Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963
[TBL] [Abstract][Full Text] [Related]
10. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
11. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Sharma R; Singh B; Mahajan M
Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
[TBL] [Abstract][Full Text] [Related]
12. [Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers].
Haj Mouhamed D; Ezzaher A; Araoud M; Neffati F; Douki W; Najjar MF
Ann Biol Clin (Paris); 2010; 68(2):143-7. PubMed ID: 20348046
[TBL] [Abstract][Full Text] [Related]
13. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
[TBL] [Abstract][Full Text] [Related]
14. Assessing the relationship of paraoxonase-1 Q192R polymorphisms and the severity of lung disease in SM-exposed patients.
Golmanesh L; Bahrami F; Pourali F; Vahedi E; Wahhabaghai H; Mehrani H; Ghanei M
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):419-25. PubMed ID: 23672526
[TBL] [Abstract][Full Text] [Related]
15. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.
Bacchetti T; Campanati A; Ferretti G; Simonetti O; Liberati G; Offidani AM
Br J Dermatol; 2013 May; 168(5):984-9. PubMed ID: 23614561
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
[TBL] [Abstract][Full Text] [Related]
18. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
